Elanco Animal Health Incorporated (ETR:5EA)

Market Cap	9.37B
Revenue (ttm)	3.91B
Net Income (ttm)	30.68M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	305.35
Forward PE	22.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	78
Open	18.87
Previous Close	19.37
Day's Range	18.87 - 18.87
52-Week Range	15.58 - 20.27
Beta	n/a
RSI	48.75
Earnings Date	Feb 24, 2026

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 9,450
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 5EA

Financial Performance

Financial numbers in USD